2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
(801) 438-1036
https://www.codiagnostics.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 155
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Dwight H. Egan | Chairman & CEO | 415.75k | N/A | 1953 |
Mr. Brian L. Brown CPA | CFO & Company Secretary | 338.92k | N/A | 1976 |
Mr. Richard David Abbott | President | N/A | N/A | 1972 |
Dr. Brent C. Satterfield Ph.D. | Co-Founder & Member of Scientific Advisory Board | 237.5k | N/A | 1977 |
Mr. David Nielsen | Chief Operating Officer | N/A | N/A | N/A |
Mr. Dan Bohrer CPA | Vice President of Finance & Accounting | N/A | N/A | N/A |
Mr. Christopher Thurston | Chief Technology Officer | N/A | N/A | N/A |
Dr. Mark Poritz Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Mr. Andrew Benson | Head of Investor Relations | N/A | N/A | N/A |
Dr. Mayuranki Almaula | Senior Vice President of Overseas Operations & Strategic Alliances | N/A | N/A | N/A |
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Co-Diagnostics, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 5; Compensation: 8.